Lantern Pharma LTRN
NASDAQ LTRN
$0.64 -0.04 (-5.88%)
At close: Oct 22, 2026 · 4:00 PM EDT

Lantern Pharma (LTRN) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Lantern Pharma (LTRN) reported Return on Capital Employed [ROCE] of -430.78% for Q2 2026, down 288.15 percentage points from -142.63% a year earlier and down 120.44 percentage points from the prior quarter.

Analysis

Lantern Pharma (LTRN) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Lantern Pharma posted Return on Capital Employed [ROCE] of -130.26%, down 56.88 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined for three consecutive years, with a four-year change of -102.17 percentage points (FY2021 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -73.37% in FY2024 (-36.56 pp), -36.81% in FY2023 (-14.12 pp), -22.69% in FY2022 (+5.39 pp) and -28.09% in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2021.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last 16 quarters, with an average year-over-year change of -119.33 percentage points over the last eight quarters.
  • Over the past five years, the year-over-year drop in Return on Capital Employed [ROCE] ranged from 4.65 percentage points (Q2 2023) to 288.15 percentage points (Q2 2026).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -310.34% (Q1 2026), -229.62% (Q4 2025) and -171.31% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 17.52%
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 17.92%
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 6.28%
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 19.32%
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 16.76%
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -5.97%
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 11.86%
10 Lantern Pharma 7.59 Mn -28.57 Mn - -430.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -430.78%
Mar 31, 2026 -310.34%
Dec 31, 2025 -229.62%
Sep 30, 2025 -171.31%
Jun 30, 2025 -142.63%
Mar 31, 2025 -111.61%
Dec 31, 2024 -94.13%
Sep 30, 2024 -72.25%
Jun 30, 2024 -59.11%
Mar 31, 2024 -51.20%
Dec 31, 2023 -41.55%
Sep 30, 2023 -35.54%
Jun 30, 2023 -30.62%
Mar 31, 2023 -26.95%
Dec 31, 2022 -25.01%
Sep 30, 2022 -23.09%
Jun 30, 2022 -25.97%
Mar 31, 2022 -20.86%
Dec 31, 2021 -16.12%
Sep 30, 2021 -11.71%
API Access

Lantern Pharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LTRN&period=max&api_key=YOUR_API_KEY